- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
New Industry Report Speculates Cannabis Sales Could hit $21.8 Billion by 2020
A new industry report forecasts that nationwide cannabis sales could reach $6.7 billion this year and grow to $21.8 billion by 2020.
A new industry report forecasts that nationwide cannabis sales could reach $6.7 billion this year and grow to $21.8 billion by 2020.
According to the press release:
The “State of Legal Marijuana Markets” report by research and investment firm the ArcView Group, states that 2016 could be a big year for cannabis in the U.S., with seven more states poised to potentially legalize it for adult use: Arizona, California, Massachusetts, Maine, Nevada, Rhode Island and Vermont. Florida, Ohio, Missouri and Pennsylvania will vote on passing medical marijuana laws.
As more cannabis markets open up, demand is expected to rise 25 percent, according to the report. Such rapid growth has led to significant challenges for the industry, including supplying a huge amount of cannabis crops without the use of potentially hazardous pesticides and making cannabis treatments safer, more discrete and more reliable for patients.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.